A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/30 (2006.01) A61K 9/06 (2006.01) A61K 31/30 (2006.01) A61K 47/08 (2006.01)
Patent
CA 2130443
2130443 9316708 PCTABS00025 A zinc depot for animals may be established through the introduction of a zinc substance exhibiting slow-release characteristics for the physiology of the animal, preferably via a non-digestive route. A fluid or paste-like composition, or a bolus, may be introduced through preferred routes such as into the bloodstream, intramuscularly, or subcutaneously. Preferred zinc substances include zinc organic salts and a specified range of preferred zinc inorganic compounds. Most exhibit a low aqueous solubility, less than or equal to 0.01 g/ml of H2O at 35 ·C. Other agents may enhance the effectiveness of the zinc substance, preferred agents including calcium, magnesium or selenium containing compounds or minerals, fatty acids, vegetable oils, and/or sulphur or sulphide compounds. The provision of a lasting zinc depot in an animal is useful for addressing zinc responsive disorders, both in a preventative and remedial sense. Examples of zinc-responsive disorders include facial eczema, fading elk's disease, mycotoxin poisoning, poisoning from alkaloid substances, disorders relating to phyto-oestrogen levels, and zinc deficiencies.
Colby Corporation Limited
Fetherstonhaugh & Co.
LandOfFree
Pharmaceutical compositions and their use for treating zinc... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and their use for treating zinc..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and their use for treating zinc... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928130